European Medicines Agency - Withdrawals of Application - Medicinal Products for Human Use - Theraloc

London, 06 March 2009
Doc. Ref: EMEA/67305/2009
WITHDRAWAL ASSESSMENT REPORT FOR THERALOC
International Nonproprietary Name:
nimotuzumab
Procedure No. EMEA/H/C/931
Day 180 Assessment Report as adopted by the CHMP with all information of a commercially confidential nature deleted.
This should be read in conjunction with the “Question and Answer” document on the withdrawal of the application: the Assessment Report may not include all available information on the product if the CHMP assessment of the latest submitted information was still ongoing at the time of the withdrawal of the application.

abrir aquí para acceder a los bloques de información en idioma inglés únicamente:
European Medicines Agency - Withdrawals of Application - Medicinal Products for Human Use - Theraloc

7 Westferry Circus, Canary Wharf, London, E14 4HB, UK
Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 86 13
E-mail: mail@emea.europa.eu. http://www.emea.europa.eu
© European Medicines Agency, 2009. Reproduction is authorised provided the source is acknowledged.